Direct advertisement created by G2, New Zealand for Arimidex, within the category: Pharmaceutical.
Can you pick which of your breast cancer patients will have a recurrence?
There’s no way to predict which of your patients will have recurring breast cancer. So it makes sense to treat all patients as women with some risk. Versus tamoxifen, Arimidex can improve every patient's chance of staying disease free.